v3.23.3

Milestones and Research Agreements | 9 Months Ended
--- | ---
Sep. 30, 2023
Milestones And Research Agreements [Abstract] |
Milestones and Research Agreements | Note 9 - Milestones and Research Agreements HBV Research Agreement with Indiana University Since September 2013, the Company has been party to an exclusive License Agreement dated September 3, 2013 with Indiana University Research and Technology Corporation (IURTC) from whom it has licensed aspects of the Company’s HBV program held by IURTC. The license agreement requires the Company to make milestone payments based upon the successful accomplishment of clinical and regulatory milestones. The aggregate amount of all performance milestone payments under the IURTC license agreement, should all milestones through development be met, is $0.8 million, with a portion having been paid. The Company is obligated to pay IURTC royalty payments based on net sales of the licensed technology as well as a portion of any sublicensing revenue Assembly receives. The Company is also required to pay diligence maintenance fees each year to the extent that the royalty, sublicensing, and milestone payments to IURTC are less than such fees for that year. The Company paid IURTC $0.1 million in diligence maintenance fees during both the nine months ended September 30, 2023 and 2022.

X
- Definition Milestones and Research Agreements + References No definition available. + Details
Name: | asmb_MilestonesAndResearchAgreementsAbstract
Namespace Prefix: | asmb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Milestones and Research Agreements + References No definition available. + Details
Name: | asmb_MilestonesAndResearchAgreementsTextBlock
Namespace Prefix: | asmb_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration